156 related articles for article (PubMed ID: 30617772)
21. Early Experience With Transanal Total Mesorectal Excision Compared With Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Propensity Score-Matched Analysis.
Alhanafy MK; Park SS; Park SC; Park B; Kim MJ; Sohn DK; Chang HJ; Oh JH
Dis Colon Rectum; 2020 Nov; 63(11):1500-1510. PubMed ID: 33044291
[TBL] [Abstract][Full Text] [Related]
22. Completely Abdominal Approach Laparoscopic Partial Intersphincteric Resection After Neoadjuvant Chemoradiation for Initial cT3 Juxta-Anal Rectal Cancer.
Huang S; Huang Y; Chi P; Lin H; Lu X; Xu Z; Sun Y; Wang X
J Laparoendosc Adv Surg Tech A; 2019 Jun; 29(6):809-816. PubMed ID: 30596539
[No Abstract] [Full Text] [Related]
23. Prognostic Implications of Pathological Response to Neoadjuvant Chemoradiation in Pathologic Stage III Rectal Cancer.
Karagkounis G; Thai L; Mace AG; Wiland H; Pai RK; Steele SR; Church JM; Kalady MF
Ann Surg; 2019 Jun; 269(6):1117-1123. PubMed ID: 31082910
[TBL] [Abstract][Full Text] [Related]
24. Low- Versus High-Risk Rectal Cancer Based on MRI Features: Outcomes in Patients Treated Without Neoadjuvant Chemoradiotherapy.
Jia XX; Wang Y; Cheng J; Yao X; Yin MJ; Zhou J; Ye YJ
AJR Am J Roentgenol; 2018 Aug; 211(2):327-334. PubMed ID: 29927331
[TBL] [Abstract][Full Text] [Related]
25. Predictive Value of CEA for Survival in Stage I Rectal Cancer: a Population-Based Propensity Score-Matched Analysis.
Tarantino I; Warschkow R; Schmied BM; Güller U; Mieth M; Cerny T; Büchler MW; Ulrich A
J Gastrointest Surg; 2016 Jun; 20(6):1213-22. PubMed ID: 27067235
[TBL] [Abstract][Full Text] [Related]
26. Can we eliminate neoadjuvant chemoradiotherapy in favor of neoadjuvant multiagent chemotherapy for select stage II/III rectal adenocarcinomas: Analysis of the National Cancer Data base.
Cassidy RJ; Liu Y; Patel K; Zhong J; Steuer CE; Kooby DA; Russell MC; Gillespie TW; Landry JC
Cancer; 2017 Mar; 123(5):783-793. PubMed ID: 27780316
[TBL] [Abstract][Full Text] [Related]
27. What factors are associated with the poor prognosis of anal adenocarcinoma compared with low-lying rectal adenocarcinoma based on a population analysis: A propensity score matching study.
Wang Q; Fu J; Chen X; Cai C; Ruan H; Du J
PLoS One; 2019; 14(7):e0219937. PubMed ID: 31361759
[TBL] [Abstract][Full Text] [Related]
28. Open versus Laparoscopic Surgery for Advanced Low Rectal Cancer: A Large, Multicenter, Propensity Score Matched Cohort Study in Japan.
Hida K; Okamura R; Sakai Y; Konishi T; Akagi T; Yamaguchi T; Akiyoshi T; Fukuda M; Yamamoto S; Yamamoto M; Nishigori T; Kawada K; Hasegawa S; Morita S; Watanabe M;
Ann Surg; 2018 Aug; 268(2):318-324. PubMed ID: 28628565
[TBL] [Abstract][Full Text] [Related]
29. Minimally Invasive Surgery for Rectal Adenocarcinoma Shows Promising Outcomes Compared to Laparotomy, a National Cancer Database Observational Analysis.
Skancke M; Schoolfield C; Umapathi B; Amdur R; Brody F; Obias V
J Laparoendosc Adv Surg Tech A; 2019 Feb; 29(2):218-224. PubMed ID: 30431390
[TBL] [Abstract][Full Text] [Related]
30. Surgical treatment of adenocarcinoma of the rectum.
Zaheer S; Pemberton JH; Farouk R; Dozois RR; Wolff BG; Ilstrup D
Ann Surg; 1998 Jun; 227(6):800-11. PubMed ID: 9637543
[TBL] [Abstract][Full Text] [Related]
31. Different Impacts of Preoperative Radiotherapy and Chemoradiotherapy on Oncological Outcomes in Patients with Stages II and III Lower Rectal Cancer: A Propensity Score Analysis.
Takiyama H; Kawai K; Ishihara S; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
Dig Surg; 2018; 35(3):212-219. PubMed ID: 28637039
[TBL] [Abstract][Full Text] [Related]
32. Endoscopic obstruction in rectal cancers: survival and recurrence patterns following curative surgery.
Hong KD; Um JW; Ji WB; Jung SY; Kang S; Lee SI; Min BW; Moon HY
J Laparoendosc Adv Surg Tech A; 2015 Apr; 25(4):278-84. PubMed ID: 25756625
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis.
Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
Oncologist; 2019 Jun; 24(6):803-811. PubMed ID: 29674444
[TBL] [Abstract][Full Text] [Related]
34. The Impact of Tumour Distance From the Anal Verge on Clinical Management and Outcomes in Patients Having a Curative Resection for Rectal Cancer.
Khan MAS; Ang CW; Hakeem AR; Scott N; Saunders RN; Botterill I
J Gastrointest Surg; 2017 Dec; 21(12):2056-2065. PubMed ID: 28924962
[TBL] [Abstract][Full Text] [Related]
35. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.
Pucciarelli S; Toppan P; Friso ML; Russo V; Pasetto L; Urso E; Marino F; Ambrosi A; Lise M
Dis Colon Rectum; 2004 Nov; 47(11):1798-807. PubMed ID: 15622571
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcomes after laparoscopic surgery versus open surgery for rectal cancer: a propensity score analysis.
Park JS; Choi GS; Jun SH; Park SY; Kim HJ
Ann Surg Oncol; 2013 Aug; 20(8):2633-40. PubMed ID: 23709099
[TBL] [Abstract][Full Text] [Related]
37. A Distal Resection Margin of ≤1 mm and Rectal Cancer Recurrence After Sphincter-Preserving Surgery: The Role of a Positive Distal Margin in Rectal Cancer Surgery.
Zeng WG; Liu MJ; Zhou ZX; Wang ZJ
Dis Colon Rectum; 2017 Nov; 60(11):1175-1183. PubMed ID: 28991082
[TBL] [Abstract][Full Text] [Related]
38. Monthly tegafur-uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: a retrospective study.
Kuo YH; Lai CH; Huang CY; Chen CJ; Huang YC; Huang WS; Chin CC
BMC Cancer; 2019 Aug; 19(1):815. PubMed ID: 31419963
[TBL] [Abstract][Full Text] [Related]
39. Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis.
Jung SM; Yu CS; Park IJ; Kim TW; Kim JH; Yoon YS; Lim SB; Kim JC
Medicine (Baltimore); 2016 May; 95(20):e3718. PubMed ID: 27196490
[TBL] [Abstract][Full Text] [Related]
40. Mucinous histology as a poor prognostic factor in young patients with Stage II rectal cancer: A population-based study.
Wu C; Bai J
J Cancer Res Ther; 2020; 16(7):1664-1671. PubMed ID: 33565514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
